Jay Mandula
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Jay Mandula
Apr 24, 2024, 10:21 |
Blog
Jay Mandula: Our recent publication from the lab of Dr. Rodriguez's at Moffitt Cancer Center in Immunity
Jay Mandula, Post Doctoral Scholar at the Ohio State University, shared on LinkedIn: "I am thrilled,…
Apr 15, 2024, 12:11 |
Blog
Jay Mandula: I have been selected as a Pelotonia Scholar via the The Pelotonia Scholars Program at the Ohio State University Comprehensive Cancer Center
Jay Mandula, Post Doctoral Scholar at the Ohio State University, shared on LinkedIn: ''I’m excited to…
Jan 10, 2024, 17:49 |
Opinion
Jay Mandula: This news is both appalling and disturbing
Jay Mandula, Post Doctoral Scholar at the Ohio State University, shared on LinkedIn: "As a cancer…
All:
3
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube